The presence of mRNA for epidermal growth factor (EGF) 
INTRODUCTION
Proliferation of human endometrium is required to repair the denuded surface of the uterus after menstruation and to prepare the endometrium for the secretory changes needed for successful implantation. The paracrine or autocrine factors regulating this profound growth of uterine cells is poorly under¬ stood. Epidermal growth factor (EGF) is a potent stimulator of proliferation in many cell types, particu¬ larly fibroblasts, keratinocytes and epithelial cells (see Carpenter & Cohen, 1979; Burgess & Lloyd, 1988) .
Evidence that EGF may be involved in endometrial proliferation includes the observations that EGF receptors are present in rat (Mukku & Stancel, 1985; Lingham, Stancel & Loose-Mitchell, 1988 ) and human endometrium (Chegini, Rao, Wakim & Sanfilippo, 1986) , prepro EGF mRNA and EGF immunoreactivity are present in mouse uterine epithelial cells (DiAugustine, Petrusz, Bell et al. 1988) and mouse uterine epithelial cell growth is enhanced by EGF (Tomooka, DiAugustine & McLachlan, 1986) . Apart from the submaxillary gland (SMG) of the mouse and, to a lesser extent, the kidney (Rail, Scott, Bell et al. 1985) , prepro mRNA is also present in low copy number in the uterus of the mouse (DiAugustine et al. 1988 ). Levels of EGF in humans are further reduced when compared with the mouse. In non-salivary glands, levels of immunoreactive EGF were 1 % of the amounts found in the mouse, whilst in the SMG they were only 0-002% of the concentrations present in mice (Hirata & Orth, 1979) . These authors did not demonstrate immunoreactive EGF in the uteri of women after cation exchange chromatography and radioimmunoassay.
There are no cited reports of EGF or its mRNA being present in human endometrium.
In addition to EGF, transforming growth factor-a (TGFa) is a ligand for the EGF receptor, and significant levels of TGFa and TGFa mRNA are found in self-renewing epithelial tissues, such as skin and gastrointestinal tract (Derynck, Roberts, Winkler et al. 1984; Derynck, Goeddel, Ullrich et al. 1987; Maiden, Novak & Burgess, 1989 (Glisin, Crkvenjakov & Byus, 1974) . After (Gubler & Hoffman, 1983) . The reverse transcriptase was inactivated by heating at 80°C for 10 min before using the cDNA.
Polymerase chain reaction (PCR) One-tenth of the cDNA (2 |il) was subject to PCR amplification using a Techne PHC-1 programmable thermocycler (Techne (Cambridge) Ltd, Duxford, (Clark, 1988 (Hanahan, 1983) . The result¬ ing colonies were screened for the presence of the correct inserts by PCR (Schofield, Vaudin, Kettle & Jones, 1989) , and mini-preparation plasmid DNA was prepared as described by Jones & Schofield (1990) .
Mini-preparation of plasmid DNA A modified alkaline-lysis procedure (Birnboim & Doly, 1979) (Sanger, Nicklen & Coulson, 1977) using a modification of the Sequenase (USB) protocol in which the DNA is denatured at 37°C for 10 min in 0-2 M NaOH, and the primer was annealed to the denatured template before precipitation (Chi, Hsueh, Hui & Tarn, 1988) . Following development of the autoradiogram, the DNA sequence was computer aligned with the previously published DNA sequences for EGF and TGFa, using the DNAid program (Dardel & Bensoussan, 1988) .
RESULTS
The most significant result of the PCR was that only by performing a second nested PCR on the cDNA was it possible reliably to obtain a dominant species of the predicted length (Figs \b and 2b) (Fig. 3) . PCR was undertaken without input cDNA to exclude the possibility of contamination of the primers which is a significant problem during PCR (Sarkar & Sommer, 1990 However, this study does suggest that endometrium figure 1. The requirement for nested polymerase chain reaction (PCR) in the detection of epidermal growth factor (EGF) cDNA from human endometrium. (a) Diagram of primer positions and strategy. Primers A and B are the external primers, whilst C and D are the internal primers used during the second-round PCR. The intron/exon boundary is shown by the arrow and, as the primers span an intron, this discriminates between the amplification of cDNA and genomic DNA. (b) Agarose gel (2%) with 123 bp ladder molecular weight marker. The result in lane 1 is of amplification using primers A and B. There are multiple non-specific products of low yield. Nested PCR using internal primers C and D results in a major product of the predicted length (252 bp (Chegini et al. 1986) , it is possible that EGF of uterine origin may have a paracrine role in human endometrial proliferation. Hirata & Orth (1979) Expression of TGFa was initially described in retrovirus-transformed fibroblasts (Todaro, Fryling & DeLarco, 1980) and later in squamous carcinomas . Recent studies, however, have shown that it is synthesized by normal epithelial skin keratinocytes (Coffey, Derynck, Wilcox et al. 1987 ).
figure 2. The (a) strategy and (b) results of polymerase chain reaction (PCR) (primers A and B, lane 3; nested primers C and D, lane 4) using primers specific for transforming growth factor-a (TGFa) on human endometrial cDNA are shown, together with the results of the similar strategy employed using epidermal growth factor-specific primers (Fig. 1) Rappolee, Mark, Banda & Werb, 19886 Kamat & Isaacson, 1987) which infiltrate the stroma in the secretory phase of the cycle and are particularly abundant in the premenstrual phase of the cycle (Bulmer, Lunny & Hagin, 1988) . In rat decidua, in-situ hybridization demonstrated the peptide in stromal but not epithe¬ lial cells (Han et al. 1987 (Lai & Guyda, 1984) and EGF could induce trophoblastic proliferation. As most of the surface epithelium and two thirds of the glandular epithelial cells are lost at menstruation (Nogales-Ortiz, Puerta & Nogales, 1978) it is also possible that TGFa, expressed by activated macro¬ phages or platelets present on the denuded surface of the endometrium, is in part responsible for the epithelial regeneration that is complete by day 5 of the menstrual cycle (Ludwig & Metzger, 1976 
